Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The online learning platform developer spun out of Stanford University priced its shares at the top of their range.

CWRU and UTMC-linked Rodeo Therapeutics is set to be acquired by Amgen for $55m in upfront and up to $666m in milestone payments.

Ohio State University spinout Entrada Therapeutics has pocketed $116m in a series B round.

MD Anderson Cancer Center spinout OncoResponse has added $40.6m to its coffers thanks to series C investors including Arch Venture Partners.

Achilles Therapeutics has raised more than $175m in its initial public offering on the Nasdaq Global Select Market.

Cash Capital has returned for OnQuality Pharmaceuticals’s latest round, having already participated in a $15m series A in 2019.

Satt Paris-Saclay’s portfolio company Altaroad has raised $11.7m in funding.

Existing backers Lilly Asia Ventures and Osage University Partners helped the UCSF cancer therapy spinout close its series A round.

The vertical take-off and landing jet developer, an Unternehmertum spinout, is joining forces with the Nasdaq-listed Qell Acquisition Corp.